Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
buxue yimu keli
- Development stage
- Phase 4
- Lead developer
- Tongji Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Buxue Yimu Keli is a Traditional Chinese Medicine (TCM) granule formulation primarily used for postpartum recovery. It is composed of several botanical extracts, typically including *Leonurus japonicus* (Motherwort), *Angelica sinensis* (Danggui), *Astragalus membranaceus* (Huangqi), *Paeonia lactiflora* (Baishao), and *Rehmannia glutinosa* (Dihuang). The formulation is designed to tonify blood and regulate menstruation, specifically addressing postpartum conditions such as anemia, lochia retention, and abdominal pain. Its therapeutic effects are attributed to its ability to promote uterine involution (contraction of the uterus) and stimulate hematopoiesis to improve red blood cell parameters. It is widely available in the Chinese pharmaceutical market and has been included in the Chinese Pharmacopoeia.
- Brand names
- Buxue Yimu Keli
- Other names
- Buxue Yimu Granules
02
Targets
AcetylcholinesteraseEPO (Erythropoietin)NOS2 (Nitric Oxide Synthase 2)IL-6 (Interleukin 6)PLA2G2A (Secretory phospholipase A2 group IIA)PLA2G4A (Cytosolic phospholipase A2 alpha)PDGFRB (Platelet-derived growth factor receptor beta)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on buxue yimu keli.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on buxue yimu keli.